Samsung Securities (016360) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
6 Jun, 2025Executive summary
FY2024 consolidated net income reached KRW 899.0bn, up 64.2% year-over-year; pretax income was KRW 1,209.6bn, up 62.0% year-over-year.
Annualized ROE improved to 12.9%, up 4.4 percentage points year-over-year.
Overseas trading value surged 131.3% year-over-year to KRW 86.9tn; retail client assets grew 2.4% to KRW 302.4tn.
Number of high-net-worth clients increased 5.6% year-over-year to 262,000.
Financial highlights
Consolidated net revenues for FY2024 were KRW 2,239.8bn, up 134.3% year-over-year; net income was KRW 899.0bn, up 64.2%.
Brokerage commission income rose 21.8% year-over-year to KRW 565.5bn, with overseas commissions up 91.7%.
Trading & interest income nearly doubled, up 97.6% year-over-year to KRW 1,054.2bn.
Financial product sales declined 35.5% year-over-year to KRW 160.8bn.
Investment banking revenue increased 25.1% year-over-year to KRW 314.8bn.
Outlook and guidance
2025 strategy targets balanced growth between retail and investment banking, with a focus on expanding revenue streams and enhancing infrastructure for high-net-worth and institutional clients.
Plans to introduce new FX services, expand into institutional-only private funds, and grow corporate lending and real estate investments.
Latest events from Samsung Securities
- FY2025 net income up 12.2% YoY, with strong brokerage and retail asset growth.016360
Q4 20259 Feb 2026 - 3Q25 net income up 28.7% YoY, ROE at 16.1%, with strong brokerage and IB growth.016360
Q3 202516 Nov 2025 - Net revenues up, but net income and ROE declined amid higher costs and expense ratios.016360
Q2 202517 Aug 2025 - 3Q24 net income up 59% YoY, driven by trading gains and robust overseas brokerage.016360
Q3 202413 Jun 2025 - 2Q24 net income up 70% YoY to KRW 257.9bn, with ROE at 15.1% and robust client asset growth.016360
Q2 202413 Jun 2025 - 1Q25 net income surged sequentially, driven by trading and fund sales, despite IB softness.016360
Q1 20256 Jun 2025